Biological Modulators in Eosinophilic Diseases.

about

Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study The Eosinophil in Health and Disease: from Bench to Bedside and Back.

P2860

Q36225538-9321E850-95A2-4D0D-8155-396163EC5905 Q38593724-91F15421-DEA1-47DE-9BEA-7F7E56868DBA

P2860

Biological Modulators in Eosinophilic Diseases.

Item

http://www.wikidata.org/entity/Q38240474

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Biological Modulators in Eosinophilic Diseases.

@en

type

Item

label

Biological Modulators in Eosinophilic Diseases.

@en

prefLabel

Biological Modulators in Eosinophilic Diseases.

@en

P1476

Biological Modulators in Eosinophilic Diseases

@en

P2093

Mark Ballow

http://www.w3.org/2001/XMLSchema#string

P2860

Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis

The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking

Eosinophilic Inflammation in Asthma

Reslizumab for Poorly Controlled, Eosinophilic Asthma

P2888

s12016-014-8444-9

P304

252-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-014-8444-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Panida Sriaroon

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001465973

http://www.w3.org/2001/XMLSchema#string

P698

25129490

http://www.w3.org/2001/XMLSchema#string

Biological Modulators in Eosinophilic Diseases.

about

P2860

P2860

Biological Modulators in Eosinophilic Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698